The stock has P/B ratio of 0.85while EPS was 0.73 ... ROE ratio was 6.30% while ROI was 14.20%. Johnson & Johnson (NYSE:JNJ) has 67% institutional ownership while its EPS ratio was CPST. The company has 2.77B shares outstanding while market … · 5/25/2015
Merck & Co. Inc. MRK and Johnson & Johnson JNJ announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has given a positive opinion in favor of expanding Simponi’s label in the EU. Simponi is …
Yahoo Finance · 1 day ago
The DJIA stock posting the largest daily percentage gain ahead of the close Monday was Johnson & Johnson (NYSE: JNJ) which traded up 1.45%% at $103.78. The stock’s 52-week range is $95.10 to $109.49. Trading volume was nearly equal to the daily …
24/7 Wall ST · 5/18/2015
More from Bing News
FreeSeas Inc. (FREE)’s monthly performance stand at -76.67% . (Click To Expand Current Stock Data:) Johnson & Johnson (JNJ) of the Healthcare sector (Drug Manufacturers – Major) is down -0.37% already this morning, a change from open of -0.22%. · 5/23/2015
Johnson Johnson
The Brentford, England-based company’s 5% dividend yield stands well above other health care giants such asJohnson & Johnson (NYSE: JNJ) and Bristol-Myers Squibb ... such huge and consistent profits in the …
ETF Daily News · 5/21/2015
GlaxoSmithKline plc
The strong dollar has hurt big multinational companies like Coca-Cola (KO), Procter & Gamble (PG) and Johnson & Johnson (JNJ). Related ... in the energy market is one of the reasons the stock market had been so …
CNN Money · ByPaul R. La · 5/26/2015
On Tuesdady, Johnson & Johnson (NYSE: JNJ) and Achillion Pharmaceuticals ... Deutsche Bank has a Buy rating on Gilead and a $125 target for the stock.
Benzinga · 5/21/2015
MIN-202 (JNJ-922) in development for primary and comorbid insomnia, MIN-117 in development for the treatment of major depressive disorder and MIN-301 in development for the treatment of Parkinson's disease. Minerva's common stock is listed on the …
Financial Content · 5/28/2015
Shares of Johnson & Johnson (NYSE:JNJ) have bearishly opened below the pivot of $103.80 ... price of $103.04 and an average consensus analyst price target of $111.23. The stock should hit resistance at its 200-day moving average (MA) of $103.16, as …
Financial News Network Online · ByMallory Stone · 5/21/2015
(LOW) Misses Q1 EPS by 4c; Comps Rose 5.3% UPDATE: Target (TGT) Tops Q1 EPS by 7c; Boosts Low-End of FY15 EPS Outlook Janssen (JNJ), Achillion (ACHN) Enter Exclusive, Global HCV Collaboration Pre-Open Stock Movers 05/20: (SRPT) (ISR) …
StreetInsider · 5/20/2015